Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Board of Directors of IMCB recommended dividends

7/30/24 GEMA

Gazprom reported for 6 months of 2024 by RAS

7/30/24 GAZP

Yuzhuralzoloto reported for 6 months of 2024 by RAS

7/30/24 UGLD

Forward Energy reported for 6 months of 2024

7/30/24 TGKJ

RBC reports for 6 months of 2024 by RAS

7/30/24 RBCM

Lenta reported for 6 months of 2024 by RAS

7/30/24 LENT

Nizhnekamskshina reported for 6 months of 2024 by RAS

7/30/24 NKSH

Lukoil reports for 6 months of 2024 by RAS

7/30/24 LKOH

MMK launched a new production facility

7/30/24 MAGN

Sovcomflot reported for 6 months of 2024 by RAS

7/30/24 FLOT